Surgeons on the medical staff of Baylor University Medical Center in Dallas, Texas now have access to high-quality images in as little as five seconds thanks to the implementation of two Carestream DRX-Revolution Mobile X-ray Systems.

Dune Medical Devices announced U.S. Food and Drug Administration (FDA) approval of an updated version of its flagship product, MarginProbe, a medical device that enables real-time detection of cancer at the surface of excised tissue specimens during breast-conserving cancer surgery.

Carestream is now the first company approved to provide the latest picture archiving and communications systems (PACS) for use in U.S. Navy medical facilities as a result of meeting some of the most stringent product security requirements for the Navy’s DIACAP certification process.

Radiologists can transmit their reports, which can also contain access to images, to their referring physicians’ electronic health records (EHR) systems securely, efficiently, and cost effectively using carefully selected technology, according to a presentation by Advanced Data Systems Corp. (ADS) at the 2014 Radiology Society of North America (RSNA) annual meeting in Chicago, Nov. 30-Dec. 5.

Blackford Analysis announced that its software has been successfully integrated into a tool developed by Massachusetts General Hospital’s Tumor Imaging Metrics Core for its Precision Imaging Metrics system that helps radiologists and oncologists coordinate to generate clinical trial imaging results with enhanced efficiency and quality.

RaySearch Laboratories AB (publ.) has entered into a long-term distribution agreement with Kamol Sukosol Electric Co. (KEC), in Bangkok, Thailand. 

Mediso Ltd. announced at the annual congress of the European Association of Nuclear Medicine the launch of new MRI subsystems with 3 and 7 Tesla field strength. 

At the IEEE medical Imaging Conference (MIC) in November, ContextVision co-presented with Texas Instruments and High Performance Consulting on new research on 3-D adaptive filtering.

EDAP TMS SA received a letter from the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on its current premarket approval (PMA) application for the Ablatherm integrated imaging device for high-intensity focused ultrasound (HIFU).

A new surgical device enables breast cancer patients to be treated with dramatically improved targeting of radiation. Findings were presented at the 18th SIS World Congress on Breast Healthcare. The congress was co-hosted by the Senologic International Society (SIS) and the American Society of Breast Disease (ASBD).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now